PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 24, 2026The Lancet821 citations

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

View Full Paper
POPatrick M. O’NeilABAndreas L. BirkenfeldBMBarbara McGowan

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

O’Neil et al. (2018) studied this question.

synapsesocial.com/papers/6a8c6055bb408d1e589d9999https://doi.org/10.1016/s0140-6736(18)31773-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Multiple Comparison Procedure for Comparing Several Treatments with a Control1955 · 5,930 citations
  2. 2Regarding Obesity as a Disease2016 · 337 citations
  3. 3Multiple Imputation for Nonresponse in Surveys1987 · 20,909 citations
  4. 4Overweight, Obesity, and Blood Pressure: The Effects of Modest Weight Reduction2000 · 332 citations
  5. 5The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.1992 · 33,990 citations